Solon Eiendom ASA operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Solon Eiendom ASA with three other
pharmaceutical manufacturers in Europe:
Cathay International Holdings Ltd
of the United Kingdom
sales of £88.59 million [US$124.24 million]
(361.65 million Polish New Zlotys [US$106.34 million]
of which 59%
was Insulin (Bioton SA)), and
based in Romania
(458.60 million Romanian Leu [US$120.75 million]
During the year ended December of 2017, sales at
Solon Eiendom ASA were NOK 883.04 million (US$112.60 million).
increase of 27.7%
versus 2016, when the company's sales were NOK 691.50 million.